Peter C Chi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5828 Temple City Blvd, Temple City, CA 91780 Phone: 626-285-1154 Fax: 626-285-1361 |
Dr. Kevin Tien Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5801 Rosemead Blvd, Temple City, CA 91780 Phone: 626-292-1241 Fax: 626-292-1746 |
Jaime Ramos, M.D Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 9810 Las Tunas Dr, Temple City, CA 91780 Phone: 626-309-7600 |
Dr. Rosina Chen, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 5807 Temple City Blvd, Suite 201, Temple City, CA 91780 Phone: 626-872-0082 Fax: 626-872-0081 |
Dr. Stella Chen, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 5807 Temple City Blvd, Temple City, CA 91780 Phone: 626-872-0082 Fax: 626-872-0081 |
Marta Irene Blesa, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5821 Temple City Blvd, Temple City, CA 91780 Phone: 626-287-8261 |
News Archive
Just a few years ago, so-called pharmacy benefit managers, or PBMs, like Medco would contract with most leading drugstore chains so people could fill their prescriptions almost anywhere they pleased. Then the PBMs realized they could operate more efficiently and profitably by limiting people's choices to a single drugstore -; their own. So they laid down the law with consumers.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.
The study, published in the September issue of the Annals of Otology, Rhinology and Laryngology, found that patients who received platelet gel reported an easier recovery than patients who received traditional packing to stop bleeding.
LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.
› Verified 5 days ago